vimarsana.com
Home
Live Updates
FDA Greenlights Imaging Agent to Detect Residual Cancer Afte
FDA Greenlights Imaging Agent to Detect Residual Cancer Afte
FDA Greenlights Imaging Agent to Detect Residual Cancer After Lumpectomy
Pegulicianine used with an approved imaging system achieved overall diagnostic accuracy of 84%
Related Keywords
California ,
United States ,
Stanford University ,
Boston ,
Massachusetts ,
Barbara Smith ,
Charles Bankhead ,
Irene Wapnir ,
Stanford University Medical Center ,
,
Lumicell Direct Visualization System ,
Mass General Brigham ,
Medpage Today ,